Brief: Fresh Tracks Therapeutics Inc Reports Q4 Revenue Of $2.1 Million
30/03/2023 21:09
March 30 (Reuters) - Fresh Tracks Therapeutics Inc
FRTX.O :
* FRESH TRACKS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* FRESH TRACKS THERAPEUTICS INC Q4 REVENUE $2.1 MILLION
* FRESH TRACKS THERAPEUTICS INC - QTRLY LOSS PER SHARE $1.50
Source text for Eikon: ID:nGNX5FvXwP
Further company coverage: FRTX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx